Body Vision Medical Closes New Funding to Expand AI Imaging Technology Globally
Body Vision Medical has secured new funding to expand its AI-powered intraoperative imaging technology, particularly in the early-stage lung disease diagnosis and treatment sector. Led by Business Asia Consultants and Sprim Global Investments, this funding aims to meet the growing demand fueled by national lung cancer screening programs worldwide. Body Vision’s LungVision technology offers real-time imaging guidance, enhancing diagnostic yield during procedures while remaining affordable.
WALTHAM, Mass., Aug. 6, 2026 /PRNewswire/ — Body Vision Medical, a global leader in AI-powered intraoperative imaging, has closed a new round of funding to capitalize on the rising demand for advanced imaging technology used to support the diagnosis and treatment of early-stage lung…